Bioton S.A. (BIO) - Financial and Strategic SWOT Analysis Review

Date: October 24, 2016
Pages: 35
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Bioton S.A. (BIO) - Financial and Strategic SWOT Analysis Review
Bioton S.A. (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Bioton S.A. (Bioton) manufactures medicines and pharmaceutical preparations and produces pharmaceutical substances. Its product portfolio includes antibiotics; anesthetic drugs and eye drops; recombinant human insulin in different forms; human growth hormone and orally taken anti-diabetic medicines. The company’s also provides strips for measurement of blood sugar and over-the-counter (OTC) preparations including diet supplements, products for particular nutritional uses and cosmetics for patients with certain health problems such as metabolic syndrome and diabetes. Bioton undertakes research activities in the areas of genetic engineering, biotechnology, and pharmacology and offers in-licensing services. The company operates in Europe, Asia and Australia. Bioton is headquartered in Ozarow Mazowiecki, Poland.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Bioton S.A. - Key Facts
Bioton S.A. - Key Employees
Bioton S.A. - Key Employee Biographies
Bioton S.A. - Major Products and Services
Bioton S.A. - History
Bioton S.A. - Company Statement
Bioton S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries


Bioton S.A. - Business Description
Bioton S.A. - Corporate Strategy
Bioton S.A. - SWOT Analysis
SWOT Analysis - Overview
Bioton S.A. - Strengths
Bioton S.A. - Weaknesses
Bioton S.A. - Opportunities
Bioton S.A. - Threats
Bioton S.A. - Key Competitors


Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts


Bioton S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Bioton S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Bioton S.A., Recent Deals Summary


Ratio Definitions
About GlobalData
Contact Us
Disclaimer 35


Bioton S.A., Key Facts
Bioton S.A., Key Employees
Bioton S.A., Key Employee Biographies
Bioton S.A., Major Products and Services
Bioton S.A., History
Bioton S.A., Subsidiaries
Bioton S.A., Key Competitors
Bioton S.A., Ratios based on current share price
Bioton S.A., Annual Ratios
Bioton S.A., Interim Ratios
Bioton S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Bioton S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Bioton S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios 34


Bioton S.A., Performance Chart (2011 - 2015)
Bioton S.A., Ratio Charts
Bioton S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Bioton S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top

PetroChina Company Limited, Company Intelligence Report US$ 1,000.00 May, 2015 · 155 pages

Ask Your Question

Bioton S.A. (BIO) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: